General Information of DTT (ID: TT5NILS)

DTT Name Cathepsin A (CTSA) DTT Info
Gene Name CTSA

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
SAR164653 DMQ98MW Diabetic complication 5A2Y Phase 1 [1]
------------------------------------------------------------------------------------
2 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
example 166 (WO2014154727) DMY3CKG Discovery agent N.A. Investigative [2]
PMID22861813C8a DM6RY4F Discovery agent N.A. Investigative [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Tolerability, safety and pharmacokinetics of the novel Cathepsin A inhibitor SAR164653 in healthy subjects.Clinical Pharmacology in Drug Development 05/2015.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1581).
3 Novel beta-amino acid derivatives as inhibitors of cathepsin A. J Med Chem. 2012 Sep 13;55(17):7636-49.